Pine Labs Ltd

Pine Labs Other Announcement

Pine Labs Limited filed CARE Ratings' Monitoring Agency Report for the quarter ended September 30, 2026, on its IPO proceeds. The report shows no deviation from objects and no major deviations.

Pine Labs Investor Presentation: Key Takeaways

Q2 FY27: Revenue ₹806 Cr (+24% YoY), Adj EBITDA ₹155 Cr (19% margin), PAT ₹39 Cr (6x YoY). Investing in mid-market, international and UPI.

Pine Labs Q2 FY27 Results: Net Profit ₹38.6 Cr, Up 543.3% YoY

Pine Labs Ltd reported revenue from operations of ₹806.2 Cr (+24.0% YoY) and net profit of ₹38.6 Cr (+543.3% YoY) for Q2 FY27.

Key figure

Net profit ₹38.6 Cr · +543.3% YoY

Pine Labs Employee Stock Options

Pine Labs granted 16,37,152 employee stock options under its ESOP 2025 scheme. Options vest over 48 months at exercise prices of Rs 5.40 to Rs 150.06.

Pine Labs Acquisition Worth ₹25 Cr

Pine Labs Limited invested ₹24.9993 Crore in its wholly owned subsidiary, Synergistic Financial Networks Private Limited, via a rights issue subscription.

Value

₹25.00 Cr

Pine Labs Board Meeting Date

Pine Labs Limited scheduled a board meeting on October 29, 2026, to consider financial results, followed by an earnings conference call.

Pine Labs Other Announcement

The company has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).